红霉素与阿奇霉素治疗小儿肺炎支原体肺炎的临床分析

Clinical analysis of erythromycin and azithromycin in the treatment of Mycoplasma pneumoniae pneumonia in children

目的探讨红霉素与阿奇霉素治疗小儿肺炎支原体肺炎的临床疗效。方法我院于2015年4月至2017年4月期间将88例小儿肺炎支原体肺炎的的患者作为研究对象。并且患者随机分成对照组和观察组,每组患者44例。其中,对照组的患儿采用红霉素的治疗方式进行治疗,而对观察组的患儿则使用红霉素联合阿奇霉素的方式进行治疗。结果两组患儿经过治疗后发现,观察组患儿治疗之后的总有效率97.73%明显高于对照组患儿的79.55%,两组患者差异显著,具有统计学意义(P<0.05)。结论通过对小儿肺炎支原体肺炎的的患者使用红霉素联合阿奇霉素的方式进行治疗之后,促进了患者身体健康的恢复,临床治疗效果显著,值得临床推广。

Objective To study the erythromycin and azithromycin treatment the clinical curative effect of pediatric mycoplasma pneumoniae pneumonia. Methods our hospital from April 2015 to April 2015 to 88 cases of infantile pneumonia mycoplasma pneumonia of the patients as the research object. And patients were randomly divided into control group and observation group,each group of 44 cases of patients. Among them,the children in the control group using erythromycin treatment for treatment,and the observation group of children use the way of erythromycin combined azithromycin for treatment. Results two groups after treatment,found that children of observation group after treatment in children with 97. 73% of the children is significantly higher than the control group total effective rate 97. 73%,two groups of patients with significant difference,statistically significant( P<0. 05). Conclusion the patients with infantile pneumonia mycoplasma pneumonia after treatment in the form of erythromycin combined azithromycin to promote the recovery of the patients health,clinical effect is significant,worthy of clinical promotion.